WallStSmart

HCA Healthcare, Inc. (HCA)vsCharming Medical Limited Class A Ordinary Shares (MCTA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HCA Healthcare, Inc. generates 1408441% more annual revenue ($76.39B vs $5.42M). MCTA leads profitability with a 12.1% profit margin vs 8.9%. HCA trades at a lower P/E of 12.5x. HCA earns a higher WallStSmart Score of 63/100 (C+).

HCA

Buy

63

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 5/9Altman Z: 1.71

MCTA

Avoid

27

out of 100

Grade: F

Growth: 7.3Profit: 5.0Value: 4.0Quality: 4.0
Piotroski: 5/9Altman Z: 1.74
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCASignificantly Overvalued (-85.7%)

Margin of Safety

-85.7%

Fair Value

$286.26

Current Price

$372.13

$85.87 premium

UndervaluedFair: $286.26Overvalued

Intrinsic value data unavailable for MCTA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCA4 strengths · Avg: 9.3/10
Return on EquityProfitability
136.3%10/10

Every $100 of equity generates 136 in profit

Debt/EquityHealth
-7.9110/10

Conservative balance sheet, low leverage

Market CapQuality
$80.58B9/10

Large-cap with strong market position

P/E RatioValuation
12.5x8/10

Attractively priced relative to earnings

MCTA1 strengths · Avg: 10.0/10
EPS GrowthGrowth
81.0%10/10

Earnings expanding 81.0% YoY

Areas to Watch

HCA2 concerns · Avg: 4.0/10
Revenue GrowthGrowth
4.3%4/10

4.3% revenue growth

Altman Z-ScoreHealth
1.714/10

Distress zone — elevated risk

MCTA4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.744/10

Distress zone — elevated risk

Market CapQuality
$504.26M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

P/E RatioValuation
419.4x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HCA

The strongest argument for HCA centers on Return on Equity, Debt/Equity, Market Cap. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bull Case : MCTA

The strongest argument for MCTA centers on EPS Growth.

Bear Case : HCA

The primary concerns for HCA are Revenue Growth, Altman Z-Score.

Bear Case : MCTA

The primary concerns for MCTA are Altman Z-Score, Market Cap, Return on Equity. A P/E of 419.4x leaves little room for execution misses. Debt-to-equity of 23.57 is elevated, increasing financial risk.

Key Dynamics to Monitor

HCA profiles as a value stock while MCTA is a declining play — different risk/reward profiles.

HCA is growing revenue faster at 4.3% — sustainability is the question.

HCA generates stronger free cash flow (895M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCA scores higher overall (63/100 vs 27/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HCA Healthcare, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.

Visit Website →

Charming Medical Limited Class A Ordinary Shares

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Charming Medical Limited, engage in the provision of beauty, wellness, and postpartum services under the Beauty Lab brand name in Hong Kong. The company is headquartered in Causeway Bay, Hong Kong.

Want to dig deeper into these stocks?